Brandon Colby Explained

Brandon Ross Colby is an American medical geneticist in Beverly Hills, California[1] and physician specializing in predictive medicine and genetic testing. He is author of Outsmart Your Genes, a book about genetics published in 2011, and he is the founder and CEO of direct-to-consumer genetic testing service Sequencing.[2]

Early life and education

Colby was born with epidermolysis bullosa simplex (EB), a rare genetic disease that causes heat-sensitivity of the skin, leading to blisters on the hands and feet when skin temperature rises. Because of his condition he had an interest in genetics early in life.

Colby holds a degree in genetics from the University of Michigan, a 2004 Medical Doctorate from Mount Sinai School of Medicine,[1] and a 2007 Master of Business Administration from Stanford University's Graduate School of Business.[3] [4]

Career

Colby founded Existence Genetics in 2005 during his second year at Stanford.[3] The business declared bankruptcy on November 21, 2012. Existence Genetics was a genetic analysis and genetic reporting company that provided the healthcare industry and health & wellness organizations with information about their clients' genes.[5]

Colby was also medical director of Existence Health, a medical practice founded in 2010 and based in Los Angeles that provided predictive medicine services to its patients based upon a person's genes.

Sequencing

Colby founded Sequencing (sequencing.com), which launched in September 2016. It hosts genomic sequencing data for individuals and for researchers, an API through which third parties can interface with the data, and an app store. The app store allows purchase of further genetic data interpretation, such as results for Alzheimer's disease.[6] Genomics Personalized Health provides genomic sequencing, EncrypGen provides secure data transfer with blockchain, and Sequencing hosts genomic data and offers interpretation of results.[7] [8] [9] A patent assigned to sequencing.com was filed in 2014.[10] [11]

In 2022, Sequencing raised five million dollars in a round of venture capital financing.[12] [13] Sequencing has been profiled as a "key company" in ResearchandMarkets.com's whole genome and exome market research reports since 2021.[14] [15]

Publications

Colby co-authored "Congenital erythropoietic porphyria: identification and expression of eight novel mutations in the uroporphyrinogen III synthase gene", which appeared in British Journal of Haematology in 2002. In 2010, Penguin Random House published Colby's Outsmart Your Genes, a book about genetic testing and predictive medicine.[16] [17] [18]

Media appearances

In April 2011, Colby appeared on the "How to Outsmart Your Genes" episode of the TV show The Doctors. Existence Genetics performed genetic testing on several of the show's guests and Colby discussed the results. The testing focused on male pattern baldness, sexual compatibility, preconception, and disease predisposition.[19]

Colby has also appeared on ABC's Good Morning America in April, 2010, and the Today Show with Megyn Kelly in 2018.[20]

See also

Further reading

External links

Notes and References

  1. Web site: Licensing details for: A 92750 . California Department of Consumer Affairs . July 16, 2024 .
  2. Web site: Rabbitt . Meghan . Tips to Outsmart Genetic Health Risks . Prevention . February 24, 2021 . July 17, 2024.
  3. Web site: Dana . Mauriello . Brandon Colby, MBA '07: Charting the Course for a Predictive Medicine Venture . Stanford Graduate School of Business . November 2, 2017 . July 17, 2024.
  4. Web site: Outsmart Your Genes Dr. Brandon Colby MD . 2023-02-26 . Sequencing.com . en.
  5. Web site: Steve Parker . Existence Genetics Ramps up for Widespread Test Service Launch, Eyes Whole-Genome Sequencing . GenomeWeb . 8 October 2010. 2011-06-01.
  6. Web site: Richards. Sarah Elizabeth. Now You Can Genetically Test Your Child For Disease Risks. Should You? . Smithsonian Magazine . February 5, 2018 . July 17, 2024.
  7. Web site: EncrypGen, Inc. Add New Alliances: Sequencing.com & Genomics Personalized Health . January 29, 2018 . Marketers Media . July 18, 2024 . Press release.
  8. DNA Can Guide the Way: Genome Mapping Offers Look Into Medical Future. Corpus Christi Caller - Times, July 07, 2016. https://www.proquest.com/newspapers/dna-can-guide-way/docview/2581329790/se-2 (accessed July 19, 2024).
  9. Web site: Sequencing.com launches genetic data platform . ProQuest . . 2024-07-19. .
  10. Web site: Researchers Submit Patent Application, "System and Method for Real-Time Personalization Utilizing an Individual'S Genomic Data", for Approval (USPTO 20160321395) . November 26, 2016 . Gale Academic OneFile . NewsRX . July 18, 2024 .
  11. Guerrini . Christi J. . Lewellyn . Meaganne . Majumder . Mary A. . Trejo . Meredith . Canfield . Isabel . McGuire . Amy L. . Donors, authors, and owners: how is genomic citizen science addressing interests in research outputs? . BMC Medical Ethics . 20 . 1 . 2019 . 84 . 1472-6939 . 31752834 . 6868686 . 10.1186/s12910-019-0419-1 . free.
  12. Web site: Sequencing.com Raises $5M In Venture Capital . November 9, 2022 . VC News Daily . Massinvestor . July 18, 2024 .
  13. "VC Health Pulse: Expected Gridlock in Washington Shifts Healthcare VCs' Attention to States; Biotech Startup Juvena Therapeutics Grabs $41 Million." Dow Jones Institutional News, November 10, 2022, https://www.proquest.com/wire-feeds/vc-health-pulse-expected-gridlock-washington/docview/2734893339/se-2 (accessed July 19, 2024).
  14. Web site: Whole Genome and Exome Sequencing Market Analysis 2023-2024 and 2027 with Executive and Consultant Guides Featuring llumina, ION, Pacific Biosystems, Roche, SOLiD, Oxford Nanopore Among Others . March 28, 2024 . PR Newswire . July 18, 2024 . Press release.
  15. Web site: Whole Genome And Exome Sequencing Markets, Q4 2021 Market Report - ResearchAndMarkets.com . October 5, 2021 . Business Wire . July 18, 2024 . Press release.
  16. Shady . Amr A. . Colby . Brandon R. . Cunha . Luis F. . Astrin . Kenneth H. . Bishop . David F. . Desnick . Robert J. . Congenital erythropoietic porphyria: identification and expression of eight novel mutations in the uroporphyrinogen III synthase gene . British Journal of Haematology . 117 . 4 . 2002 . 0007-1048 . 10.1046/j.1365-2141.2002.03558.x . 980–987. 12060141 .
  17. Brendan Colby. Outsmart Your Genes: How Understanding Your DNA Will Empower You to Protect Yourself Against Cancer, Alzheimer's, Heart Disease, Obesity, and Many Other Conditions. Penguin, 2010.
  18. Andrea Hoffmann and Panagiotis A Tsonis. Book Review: Outsmart Your Genes Human Genomics 2011, 5:516-517
  19. Web site: Show Synopsis . https://web.archive.org/web/20110426061944/http://www.thedoctorstv.com/main/show_synopsis/741?section=synopsis . dead . 2011-04-26 . Thedoctorstv.com . 2011-06-01 .
  20. Kelly, Megyn. A look at the story of Taylor Muhl. Today (Feb 23, 2018), https://www.proquest.com/other-sources/look-at-story-taylor-muhl/docview/2008176519/se-2 (accessed July 19, 2024).

This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article "Brandon Colby".

Except where otherwise indicated, Everything.Explained.Today is © Copyright 2009-2024, A B Cryer, All Rights Reserved. Cookie policy.